ASK REDCHAT ANYTHING ABOUT KINIKSA PHARMACEUTICALS, LTD.
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA)
Listen to this Section
$56.95
+0.0600
(
+0.11% )
N/A
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Abiprubart (KPL-404) (CD40)DetailsAutoimmune disease, Sjögren-Larsson Syndrome |
Phase 2b |
| Abiprubart (KPL-404) (CD40)DetailsAutoimmune disease, Rheumatoid arthritis |
Phase 2 |
| Mavrilimumab (GM-CSFRa)DetailsInflammatory disease, Giant cell arteritis |
Failed |
| Mavrilimumab (GM-CSFRa)DetailsCOVID-19, Pneumonia |
Failed |
Market Data
|
| Open |
$56.95 |
| Previous Close |
$56.89 |
| Volume |
N/A |
| Market Cap |
$4.55B |
| Day Range |
$56.97 - $57.45 |
| 52 Week Range |
$26.27 - $61.12 |
| Shares Outstanding |
76.94M |
| Change % |
+0.11% |
| Net Change |
▲ 0.0600 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Year | 2018 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-449,791.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-25 |
Sale |
-136124.00 |
Patel Sanj K |
| 2024-07-25 |
Sale |
-22000.00 |
Paolini John F. |
| 2024-07-25 |
Sale |
-24248.00 |
Ragosa Mark |
| 2024-06-07 |
Sale |
-6346.00 |
BAKER BROS. ADVISORS LP |
| 2024-06-07 |
Sale |
-4373.00 |
Levy Richard S |
| 2024-06-07 |
Sale |
-4373.00 |
McCain Tracey L |
| 2024-06-07 |
Sale |
-4373.00 |
Malley Thomas |
| 2024-06-07 |
Sale |
-4373.00 |
Cole G Bradley |
| 2024-06-07 |
Sale |
-4373.00 |
Quart Barry D |
| 2024-06-07 |
Sale |
-4373.00 |
Popovits Kimberly J |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Sep 08, 2025 |
| 4 |
Insider transactions |
1 |
Sep 08, 2025 |
| 8-k |
8K-related |
55 |
Sep 03, 2025 |
| 4 |
Insider transactions |
1 |
Sep 03, 2025 |
| 4 |
Insider transactions |
1 |
Sep 03, 2025 |
| 4 |
Insider transactions |
1 |
Sep 03, 2025 |
| 4 |
Insider transactions |
1 |
Sep 03, 2025 |
| 4 |
Insider transactions |
1 |
Sep 03, 2025 |
| 4 |
Insider transactions |
1 |
Sep 03, 2025 |
| 4 |
Insider transactions |
1 |
Aug 20, 2025 |